Literature DB >> 16961595

Angiogenin: a review of the pathophysiology and potential clinical applications.

A Tello-Montoliu1, J V Patel, G Y H Lip.   

Abstract

Angiogenin is a member of the ribonuclease (RNase) superfamily: enzymes of innate substrate specificity, but divergent functional capacities. Angiogenin is a normal constituent of the circulation and contained in a vasculature that rarely undergoes proliferation, but in some physiological and pathological conditions its levels increase in blood, promoting neovascularization. Hence, angiogenesis is a common pathophysiological attribute of angiogenin. In malignant disease, the most studied pathological state in regard to angionenin, abnormally high levels are seen, which may be of prognostic significance. Angiogenin has also been studied in other non-malignant pathological states. The aim of this review article is to provide an overview of the biochemistry and physiology of angiogenin, specifically in relation to the human pathological states where angiogenin has been implicated and finally, its potential clinical applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961595     DOI: 10.1111/j.1538-7836.2006.01995.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  78 in total

Review 1.  Molecular imaging with nucleic acid aptamers.

Authors:  H Hong; S Goel; Y Zhang; W Cai
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  RNase A ribonucleases and host defense: an evolving story.

Authors:  Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2008-01-22       Impact factor: 4.962

3.  Transcription of angiogenin and ribonuclease 4 is regulated by RNA polymerase III elements and a CCCTC binding factor (CTCF)-dependent intragenic chromatin loop.

Authors:  Jinghao Sheng; Chi Luo; Yuxiang Jiang; Philip W Hinds; Zhengping Xu; Guo-fu Hu
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

4.  Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration.

Authors:  Sujoy Dutta; Chirosree Bandyopadhyay; Virginie Bottero; Mohanan V Veettil; Lydia Wilson; Michael R Pins; Karen E Johnson; Case Warshall; Bala Chandran
Journal:  Mol Oncol       Date:  2014-01-04       Impact factor: 6.603

5.  Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration.

Authors:  Vitali Alexeev; Julio Cesar Salas-Alanis; Francis Palisson; Lila Mukhtarzada; Giulio Fortuna; Jouni Uitto; Andrew South; Olga Igoucheva
Journal:  J Invest Dermatol       Date:  2017-07-20       Impact factor: 8.551

6.  Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress.

Authors:  Mridusmita Saikia; Raul Jobava; Marc Parisien; Andrea Putnam; Dawid Krokowski; Xing-Huang Gao; Bo-Jhih Guan; Yiyuan Yuan; Eckhard Jankowsky; Zhaoyang Feng; Guo-fu Hu; Marianne Pusztai-Carey; Madhavi Gorla; Naresh Babu V Sepuri; Tao Pan; Maria Hatzoglou
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

7.  The impact of skeletal muscle contraction on CD146+Lin- pericytes.

Authors:  Svyatoslav Dvoretskiy; Koyal Garg; Michael Munroe; Yair Pincu; Ziad S Mahmassani; Charlotte Coombs; Brent Blackwell; Gabriela Garcia; Garret Waterstradt; Isaac Lee; Jenny Drnevich; Justin S Rhodes; Marni D Boppart
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-21       Impact factor: 4.249

8.  Angiogenin as a molecular target for the treatment of prostate cancer.

Authors:  Shuping Li; Soichiro Ibaragi; Guo-Fu Hu
Journal:  Curr Cancer Ther Rev       Date:  2011-05

Review 9.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

10.  Mutational dynamics of murine angiogenin duplicates.

Authors:  Francisco M Codoñer; Silvia Alfonso-Loeches; Mario A Fares
Journal:  BMC Evol Biol       Date:  2010-10-15       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.